找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hypofractionated and Stereotactic Radiation Therapy; A Practical Guide Orit Kaidar-Person,Ronald Chen Book 20181st edition Springer Interna

[復(fù)制鏈接]
樓主: 喝水
21#
發(fā)表于 2025-3-25 04:18:49 | 只看該作者
Hypofractionated and Stereotactic Radiation TherapyA Practical Guide
22#
發(fā)表于 2025-3-25 10:17:55 | 只看該作者
23#
發(fā)表于 2025-3-25 14:31:20 | 只看該作者
24#
發(fā)表于 2025-3-25 19:47:16 | 只看該作者
ng from commonly-used dose-fractionation schemes for hypofractionated and stereotactic body radiotherapy to simulation and treatment specifications to published safety and efficacy data. Chapters additionally e978-3-319-92800-5978-3-319-92802-9
25#
發(fā)表于 2025-3-25 22:00:36 | 只看該作者
Book 20181st editioniation therapy, which consists of larger-dose radiation treatments that are given over a shorter time period compared to conventional radiation fraction sizes, is used to treat a variety of cancers, including prostate, breast, lung,? and colorectal.? Conventional radiation therapy and hypofractionat
26#
發(fā)表于 2025-3-26 00:50:34 | 只看該作者
27#
發(fā)表于 2025-3-26 07:14:58 | 只看該作者
28#
發(fā)表于 2025-3-26 11:16:18 | 只看該作者
,?Naturcode? – Natur, Medien und Werte,ing noninvasive. This chapter summarizes the use of hypofractionated RT, focusing on SBRT, for nasopharyngeal carcinoma in the definitive setting where it is used as a boost to traditional EBRT, as well as in the re-irradiation setting.
29#
發(fā)表于 2025-3-26 15:11:27 | 只看該作者
The Physics of Hypofractionation and SRS/SBRT,nes the physics of hypofractionation by starting with definitions and basic premise, reviewing some currently available delivery systems, and finally discussing safety measures and important QA procedures at each step of the treatment process, from simulation to delivery.
30#
發(fā)表于 2025-3-26 16:52:39 | 只看該作者
Glioblastomaation. Patients older than 65–70 with good performance status are candidates for hypofractionated RT ± concurrent and adjuvant temozolomide. Patients with poor performance status can be considered for hypofractionated RT alone, temozolomide alone, or palliative/best supportive care based on MGMT methylation status and overall clinical picture.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 02:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
漠河县| 盐池县| 楚雄市| 永宁县| 班戈县| 镇赉县| 和林格尔县| 南投市| 措勤县| 济南市| 法库县| 吴川市| 连江县| 治多县| 夏津县| 拉萨市| 永康市| 开江县| 浦城县| 宁明县| 天等县| 白玉县| 正定县| 肥东县| 济南市| 南汇区| 阳谷县| 德州市| 阳春市| 花垣县| 彭山县| 梁河县| 昭平县| 上栗县| 阿鲁科尔沁旗| 潼关县| 泽州县| 肇东市| 沁水县| 克拉玛依市| 阳信县|